메뉴 건너뛰기




Volumn 45, Issue 1, 2013, Pages 44-48

A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: Results of a 20 year audit

Author keywords

Audit; Cytology; Diagnosis; Effusion; Mesothelioma

Indexed keywords


EID: 84873857892     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32835bc848     Document Type: Article
Times cited : (107)

References (37)
  • 2
    • 26444458845 scopus 로고    scopus 로고
    • Advances in malignant mesothelioma
    • Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-603.
    • (2005) N Engl J Med , vol.353 , pp. 1591-1603
    • Robinson, B.W.1    Lake, R.A.2
  • 3
    • 0031038316 scopus 로고    scopus 로고
    • The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma
    • Renshaw AA, Dean BR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111: 106-9.
    • (1997) Chest , vol.111 , pp. 106-109
    • Renshaw, A.A.1    Dean, B.R.2    Antman, K.H.3
  • 4
    • 20244382239 scopus 로고    scopus 로고
    • The separation of benign and malignant mesothelial proliferations
    • Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000; 24: 1183-200.
    • (2000) Am J Surg Pathol , vol.24 , pp. 1183-1200
    • Churg, A.1    Colby, T.V.2    Cagle, P.3
  • 5
    • 45149084771 scopus 로고    scopus 로고
    • Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • Stahel RA, Weder W, Felip E. Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl 2): ii43-4.
    • (2008) Ann Oncol , vol.19 , Issue.SUPPL. 2
    • Stahel, R.A.1    Weder, W.2    Felip, E.3
  • 6
    • 69149105448 scopus 로고    scopus 로고
    • Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group
    • Husain AN, Colby TV, Ordonez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133: 1317-31.
    • (2009) Arch Pathol Lab Med , vol.133 , pp. 1317-1331
    • Husain, A.N.1    Colby, T.V.2    Ordonez, N.G.3
  • 7
    • 0027315218 scopus 로고
    • Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
    • Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72: 389-93.
    • (1993) Cancer , vol.72 , pp. 389-393
    • Boutin, C.1    Rey, F.2
  • 8
    • 50049122654 scopus 로고    scopus 로고
    • The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma
    • Attanoos RL, Gibbs AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology 2008; 53: 340-4.
    • (2008) Histopathology , vol.53 , pp. 340-344
    • Attanoos, R.L.1    Gibbs, A.R.2
  • 9
    • 44649195806 scopus 로고    scopus 로고
    • Prophylactic radiotherapy for pleural puncture sites in mesothelioma: The controversy continues
    • Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med 2008; 14: 326-30.
    • (2008) Curr Opin Pulm Med , vol.14 , pp. 326-330
    • Davies, H.E.1    Musk, A.W.2    Lee, Y.C.3
  • 10
    • 70350294133 scopus 로고    scopus 로고
    • Prophylactic radiotherapy to intervention sites in mesothelioma: A systematic review and survey of UK practice
    • Lee C, Bayman N, Swindell R, et al. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer 2009; 66: 150-6.
    • (2009) Lung Cancer , vol.66 , pp. 150-156
    • Lee, C.1    Bayman, N.2    Swindell, R.3
  • 11
    • 0142197139 scopus 로고    scopus 로고
    • Malignant mesothelioma in Australia, 1945-2002
    • Leigh J, Driscoll T. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 2003; 9: 206-17.
    • (2003) Int J Occup Environ Health , vol.9 , pp. 206-217
    • Leigh, J.1    Driscoll, T.2
  • 12
    • 0034095794 scopus 로고    scopus 로고
    • The cytology of malignant mesothelioma
    • Whitaker D. The cytology of malignant mesothelioma. Cytopathology 2000; 11: 139-51.
    • (2000) Cytopathology , vol.11 , pp. 139-151
    • Whitaker, D.1
  • 13
    • 20444363792 scopus 로고    scopus 로고
    • Asbestos and mesothelioma: Worldwide trends
    • Kazan-Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer 2005; 49 (Suppl 1): S3-8.
    • (2005) Lung Cancer , vol.49 , Issue.SUPPL. 1
    • Kazan-Allen, L.1
  • 14
    • 0003911911 scopus 로고
    • College of American Pathologists Committee on Nomenclature and Classification of Disease. Chicago: College of American Pathologists
    • College of American Pathologists Committee on Nomenclature and Classification of Disease. Systematized Nomenclature of Pathology. Chicago: College of American Pathologists, 1965.
    • (1965) Systematized Nomenclature of Pathology
  • 16
    • 0032907641 scopus 로고    scopus 로고
    • Fine needle aspiration or core biopsy
    • Britton P. Fine needle aspiration or core biopsy. Breast 1999; 8: 1-4.
    • (1999) Breast , vol.8 , pp. 1-4
    • Britton, P.1
  • 17
    • 0006288480 scopus 로고
    • Cytological appearances of malignant mesothelioma
    • Henderson D, Shilkin K, Langlois S, et al., editors. New York: Hemisphere
    • Whitaker D, Sterrett G, Shilkin K. Cytological appearances of malignant mesothelioma. In: Henderson D, Shilkin K, Langlois S, et al., editors. Malignant Mesothelioma. New York: Hemisphere, 1992; 167-82.
    • (1992) Malignant Mesothelioma , pp. 167-182
    • Whitaker, D.1    Sterrett, G.2    Shilkin, K.3
  • 18
    • 0025341209 scopus 로고
    • Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma
    • Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990; 114: 845-51.
    • (1990) Arch Pathol Lab Med , vol.114 , pp. 845-851
    • Sherman, M.E.1    Mark, E.J.2
  • 19
    • 33745019181 scopus 로고    scopus 로고
    • Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma
    • Butnor KJ, Nicholson AG, Allred DC, et al. Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma. Arch Pathol Lab Med 2006; 130: 823-7.
    • (2006) Arch Pathol Lab Med , vol.130 , pp. 823-827
    • Butnor, K.J.1    Nicholson, A.G.2    Allred, D.C.3
  • 20
    • 72149101492 scopus 로고    scopus 로고
    • Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: Pleural effusions with malignant epithelioid cells
    • Westfall DE, Fan X, MarchevskyAM.Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol 2010; 38: 9-14.
    • (2010) Diagn Cytopathol , vol.38 , pp. 9-14
    • Westfall, D.E.1    Fan, X.2    Marchevsky, A.M.3
  • 21
    • 0035075293 scopus 로고    scopus 로고
    • Benign and malignant mesothelial proliferations
    • Koss LG. Benign and malignant mesothelial proliferations. Am J Surg Pathol 2001; 25: 548-9.
    • (2001) Am J Surg Pathol , vol.25 , pp. 548-549
    • Koss, L.G.1
  • 22
    • 33746605601 scopus 로고    scopus 로고
    • The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant
    • Aerts JG, Delahaye M, van der Kwast TH, et al. The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant. Diagn Cytopathol 2006; 34: 523-7.
    • (2006) Diagn Cytopathol , vol.34 , pp. 523-527
    • Aerts, J.G.1    Delahaye, M.2    Van Der Kwast, T.H.3
  • 23
    • 33645275721 scopus 로고    scopus 로고
    • Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: Identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
    • Yaziji H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006; 19: 514-23.
    • (2006) Mod Pathol , vol.19 , pp. 514-523
    • Yaziji, H.1    Battifora, H.2    Barry, T.S.3
  • 24
    • 33845341114 scopus 로고    scopus 로고
    • What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update
    • Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 2007; 38: 1-16.
    • (2007) Hum Pathol , vol.38 , pp. 1-16
    • Ordonez, N.G.1
  • 25
    • 0036122832 scopus 로고    scopus 로고
    • Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
    • Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002; 40: 237-44.
    • (2002) Histopathology , vol.40 , pp. 237-244
    • Attanoos, R.L.1    Webb, R.2    Dojcinov, S.D.3
  • 26
    • 0343238145 scopus 로고    scopus 로고
    • Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma
    • Ordonez NG. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 2000; 24: 598-606.
    • (2000) Am J Surg Pathol , vol.24 , pp. 598-606
    • Ordonez, N.G.1
  • 27
    • 0034145199 scopus 로고    scopus 로고
    • Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas
    • Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000; 7: 123-7.
    • (2000) Adv Anat Pathol , vol.7 , pp. 123-127
    • Ordonez, N.G.1
  • 28
    • 0141613691 scopus 로고    scopus 로고
    • The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2
    • Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003; 43: 231-8.
    • (2003) Histopathology , vol.43 , pp. 231-238
    • Attanoos, R.L.1    Griffin, A.2    Gibbs, A.R.3
  • 29
    • 13844252069 scopus 로고    scopus 로고
    • The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study
    • Saad RS, Cho P, Liu YL, et al. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study. Diagn Cytopathol 2005; 32: 156-9.
    • (2005) Diagn Cytopathol , vol.32 , pp. 156-159
    • Saad, R.S.1    Cho, P.2    Liu, Y.L.3
  • 30
    • 43249083136 scopus 로고    scopus 로고
    • Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
    • Creaney J, Segal A, Sterrett G, et al. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Br J Cancer 2008; 98: 1562-9.
    • (2008) Br J Cancer , vol.98 , pp. 1562-1569
    • Creaney, J.1    Segal, A.2    Sterrett, G.3
  • 31
    • 65349097940 scopus 로고    scopus 로고
    • Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids
    • Shen J, Pinkus GS, Deshpande V, et al. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 2009; 131: 516-23.
    • (2009) Am J Clin Pathol , vol.131 , pp. 516-523
    • Shen, J.1    Pinkus, G.S.2    Deshpande, V.3
  • 32
    • 77952561875 scopus 로고    scopus 로고
    • The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions
    • Hasteh F, Lin GY, Weidner N, et al. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90-6.
    • (2010) Cancer Cytopathol , vol.118 , pp. 90-96
    • Hasteh, F.1    Lin, G.Y.2    Weidner, N.3
  • 33
    • 0021282013 scopus 로고
    • Diagnosis of pleural malignant mesothelioma in life - A practical approach
    • Whitaker D, Shilkin K. Diagnosis of pleural malignant mesothelioma in life - a practical approach. J Pathol 1984; 143: 147-75.
    • (1984) J Pathol , vol.143 , pp. 147-175
    • Whitaker, D.1    Shilkin, K.2
  • 34
  • 35
    • 0026769458 scopus 로고
    • Malignant mesothelioma: Cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation
    • Leong AS, Stevens MW, Mukherjee TM. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation. Semin Diagn Pathol 1992; 9: 141-50.
    • (1992) Semin Diagn Pathol , vol.9 , pp. 141-150
    • Leong, A.S.1    Stevens, M.W.2    Mukherjee, T.M.3
  • 36
    • 0026785081 scopus 로고
    • Cytopathology of malignant mesothelioma: A stepwise logistic regression analysis
    • Stevens MW, Leong AS, Fazzalari NL, et al. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 1992; 8: 333-41.
    • (1992) Diagn Cytopathol , vol.8 , pp. 333-341
    • Stevens, M.W.1    Leong, A.S.2    Fazzalari, N.L.3
  • 37
    • 19644385820 scopus 로고    scopus 로고
    • Pleural biopsy: A reliable method for determining the diagnosis but not subtype in mesothelioma
    • Bueno R, Reblando J, Glickman J, et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 2004; 78: 1774-6.
    • (2004) Ann Thorac Surg , vol.78 , pp. 1774-1776
    • Bueno, R.1    Reblando, J.2    Glickman, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.